arrow
BackJournal Details
Blood Cancer Journal cover

Blood Cancer Journal

IF11.6
Papers2270
Citations8358
Journal Papers 2208
Publication Date
Overall survival of Black patients with newly diagnosed multiple myeloma in the era of triplet and quadruplet therapies
delete2026-10-07
delete0
deleteOAAI
deleteHamlet Gasoyan; Shahzad Raza; Michael B. Rothberg; Jeffrey D. Kovach; Nicholas J. Casacchia; Jason Valent; Faiz Anwer
deleteShare
deleteSave
SETD2 is a novel and druggable dependency in IMiD/CELMoD resistant multiple myeloma models
delete2026-10-06
delete0
deleteOAAI
deleteSarah A. Bird; Marco P. Licciardello; Salomon Morales; Mara Mandelia; Enze Liu; Yakinthi Chrisochoidou; James Smith; Amy Wilson; Jack Cheung; Shannon Martin; Yigen Li; Fernando J. Sialana; Brian A. Walker; Paul A. Clarke; Charlotte Pawlyn
deleteShare
deleteSave
Early post-transplant molecular residual disease predicts outcomes in myelodysplastic neoplasms/syndromes and acute myeloid leukemia undergoing allogeneic transplantation
delete2026-10-01
delete0
deleteOAAI
deleteWan-Hsuan Lee; Xavier Cheng-Hong Tsai; Chien-Chin Lin; Feng-Ming Tien; Min-Yen Lo; Yu-Sung Chang; Tai-Chung Tseng; Tai-Chung Huang; Bor-Sheng Ko; Ming Yao; Yen-Ling Peng; Mei-Hsuan Tseng; Yuan-Yeh Kuo; Ming-Chih Liu; Szu-Hwei Lee; Chi-Yuan Yao; Chang-Tsu Yuan; Shan-Chi Yu; Hwei-Fang Tien; Hsin-An Hou; Wen-Chien Chou
deleteShare
deleteSave
Infection risk and management in patients with relapsed/refractory multiple myeloma treated with linvoseltamab in the LINKER-MM1 study
delete2026-10-01
delete0
deleteOAAI
deleteJoshua Richter; Madhav Dhodapkar; Mansi R. Shah; Joaquín Martinez-Lopez; Mina Awad; C. Akunna Otele; Mengying Li; Christian Hampp; Wenying Deng; Katherine Knorr; Tito Roccia; Glenn S. Kroog; Paula Rodríguez-Otero
deleteShare
deleteSave
Bridging therapy response and type as determinants of cilta-cel outcomes in relapsed/refractory multiple myeloma
delete2026-10-01
delete0
deleteOAAI
deleteDoris K. Hansen; Brett M. Reid; Ariel Grajales-Cruz; Peter Cheng; Zhuoer Xie; Brandon Blue; Dae Hyun Lee; Laura Oswald; Gabriel De Avila; David Scheiber-Camoretti; Ken Harada; Daniel De Avila; Brandon Kale; Karla Feliciano Salva; David Kaldas; Kristy Matte; Todd Stinard; Rebecca Gonzalez; Victoria Alegria; Matthew Perciavalle; Helen Pai; Mukta Sharma; Kevin C. De Braganca; Zaina P. Qureshi; Fabiana Perna; Hien Liu; Kenneth H. Shain; Rachid Baz; Taiga Nishihori; Melissa Alsina; Ciara L. Freeman; Omar Alexis Castaneda Puglianini; Frederick L. Locke; Lauren C. Peres
deleteShare
deleteSave
Prognostic impact of need for re-induction based on day-14 residual disease and age-adapted consolidation strategy in acute myeloid leukemia
delete2026-09-30
delete0
deleteOAAI
deleteAbiola Bolarinwa; Muhammad Yousuf; Aref Al-Kali; Hassan B. Alkhateeb; Abhishek A. Mangaonkar; Antoine N. Saliba; Mehrdad Hefazi Torghabeh; Aasiya Matin; Michelle A. Elliott; Mark R. Litzow; William J. Hogan; Mithun V. Shah; Mrinal M. Patnaik; Animesh Pardanani; Dong Chen; Kaaren K. Reichard; Rong He; Naseema Gangat; Ayalew Tefferi; Kebede H. Begna
deleteShare
deleteSave
Redefining the role of second transplantation in adult ALL with post-transplant relapse in the modern era of immuno-targeted therapies
delete2026-09-30
delete0
deleteOAAI
deleteJaehyun Ahn; Daehun Kwag; Gi June Min; Sung-Soo Park; Silvia Park; Sung-Eun Lee; Byung-Sik Cho; Ki-Seong Eom; Yoo-Jin Kim; Hee-Je Kim; Chang-Ki Min; Seok-Goo Cho; Jae-Ho Yoon
deleteShare
deleteSave
Real-world treatment patterns and outcomes of brentuximab vedotin–based therapy in CD30-positive lymphomas in China: the prospective BRAVE study
delete2026-09-30
delete0
deleteOAAI
deleteMing-Ci Cai; Ou Bai; Hui-Lai Zhang; Chuan-Xu Liu; Wen-Yang Huang; Li-Hong Liu; Zeng-Jun Li; Lu-Qun Wang; Li-Ping Su; Wei Zhang; Wei Xu; Kai-Yang Ding; Guo-Hui Cui; Hong-Mei Jing; Hua-Qing Wang; Zheng Ge; Fang Zhu; Fei Li; Xiao-Bo Wang; Shen-Miao Yang; Bing Xu; Ying Lu; Yu-Fu Li; Ting Niu; Ke-Qian Shi; Cai-Xia Li; Zhen-Qian Huang; Hong Liu; Ling Qin; Shao-Jie Wu; Hong-Yu Zhang; Jian-Li Wang; Wen-Xin Zhang; Wei-Li Zhao
deleteShare
deleteSave
High MECOM protein levels confer adverse prognosis in acute myeloid leukemia independent of Chromosome 3 abnormalities
delete2026-09-30
delete0
deleteOAAI
deleteSteven M. Kornblau; Eduardo Sabino de Camargo Magalhães; Brandon D. Brown; Samanta Soledad Catueno; Yihua Qiu; Eitan Kugler; Abhishek Maiti; Warren C. Fiskus; Tapan Kadia
deleteShare
deleteSave
End-of-induction circulating tumor DNA outperforms conventional cellular MRD for predicting early progression in follicular lymphoma: an ancillary study of the RELEVANCE randomized trial
delete2026-09-29
delete0
deleteOAAI
deleteAlexis Claudel; Pierre-Julien Viailly; Pierre Feugier; Cedric Rossi; Jessie Bourcier; Francois Lemonnier; Vincent Camus; Vincent Ribrag; Eric Durot; Gian Matteo Pica; Emmanuelle Nicolas-Virelizier; Benoit Tessoulin; Emmanuel Bachy; Stephanie Guidez; Nicolas Daguindau; Clementine Sarkozy; Luc Xerri; Cedric Portugues; Nesrine Trabelsi; Franck Morschhauser; Marie-Helene Delfau-Larue
deleteShare
deleteSave
Hypogammaglobulinemia, neutropenia, and lymphopenia, and risk for infection and mortality in patients following daratumumab for multiple myeloma
delete2026-09-28
delete0
deleteOAAI
deleteJoseph S. Hong; Lingxiao Zhang; Baijun Zhou; Katherine J. Liu; Andrew J. Yee; Sara Barmettler
deleteShare
deleteSave
Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia
delete2026-09-26
delete0
deleteOAAI
deletePaul J. Hampel; Ying Huang; John N. Allan; Seema A. Bhat; David Bond; Danielle M. Brander; John C. Byrd; Julio C. Chavez; Elise Chong; Alexey Danilov; Matthew S. Davids; Kaitlyn Dvorak-Kornaus; Hannah Freedman; Nikita Malakhov; Matthew Matasar; Cecelia Miller; Sarah Miller; Zulfa Omer; Sameer A. Parikh; Erin M. Parry; Kari G. Rabe; Phil Raess; Manoj Rai; Joanna M. Rhodes; Kerry A. Rogers; Aditi Saha; Jake Schade; Geoffrey Shouse; Stephen Spurgeon; Deborah Stephens; Yucai Wang; Jennifer A. Woyach; Max Yano; Adam S. Kittai
deleteShare
deleteSave
Daratumumab ± pomalidomide maintenance after salvage autologous transplantation in relapsed multiple myeloma: a phase 2 study
delete2026-09-26
delete0
deleteOAAI
deleteOren Pasvolsky; Bruno Almeida Costa; Yosra M. Aljawai; Krina K. Patel; Qaiser Bashir; Dawen Sui; Samer A. Srour; Mark R. Tanner; Uday R. Popat; Neeraj Y. Saini; Chitra Hosing; Jeremy L. Ramdial; Hans C. Lee; Gregory P. Kaufman; Sheeba K. Thomas; Donna M. Weber; Melody Becnel; Guilin Tang; Robert Z. Orlowski; Richard E. Champlin; Yago Nieto; Elizabeth J. Shpall; Muzaffar H. Qazilbash
deleteShare
deleteSave
Clinical, cytogenetic, and germline genetic determinants of arterial thromboembolism in IMiD-treated multiple myeloma
delete2026-09-24
delete0
deleteOAAI
deleteSina A. Beer; David A. Cairns; Molly Went; Philip Law; Amy Holroyd; Elsa Ferris; Charlotte Pawlyn; Gordon Cook; Mark Drayson; Kevin Boyd; Faith E. Davies; Matthew Jenner; Gareth J. Morgan; Graham Jackson; Richard Houlston; Martin F. Kaiser
deleteShare
deleteSave
Comparative efficacy and safety of CD19 chimeric antigen receptor T-cell therapy versus CD3/CD20 bispecific antibodies in relapsed/refractory mantle cell lymphoma: a meta-analysis of clinical trials and real-world studies
delete2026-09-23
delete0
deleteOAAI
deleteJulia Wang; Justin Desroches; Fang Yang; Dongni Yi; Yajuan Gao; Robin R. Klebig; Jonas Paludo; Ivana N. Micallef; Muhamad Alhaj Moustafa; Madiha Iqbal; Julio C. Chavez; Javier L. Munoz; Yi Lin; Yucai Wang; Jithma P. Abeykoon
deleteShare
deleteSave
The mutational landscape of resistance to BTK and BCL2 inhibitors in CLL: a real-world multicentric study
delete2026-09-22
delete0
deleteOAAI
deleteMiguel Bastos-Boente; María García-Álvarez; Cristina Jiménez; Alicia Antón; Ana Balanzategui; María Eugenia Sarasquete; Alejandro Medina; Rebeca Maldonado; David Alonso-Castronuño; María J. Vidal; Erik de Cabo; Beatriz González-Mena; José María Alonso-Alonso; Emilia Pardal; Francisco Javier Díaz-Gálvez; Luis García; José A. Queizán; María Jesús Peñarrubia; Abelardo Bárez; Carlos Aguilar; Cristina de Ramon; Norma C. Gutiérrez; Ramón García-Sanz; Marcos González; Almudena Navarro-Bailón; Miguel Alcoceba
deleteShare
deleteSave
Long-term survival and cause-specific mortality after event-free survival at 24 months (EFS24) in mantle cell lymphoma: an international multicohort study
delete2026-09-22
delete0
deleteOAAI
deleteYucai Wang; Melissa C. Larson; Umar Farooq; Sara Ekberg; Karin E. Smedby; Mikkel R. Simonsen; Peter de Nully Brown; Carsten U. Niemann; Eric J. Zhao; Alina S. Gerrie; Jeffrey M. Switchenko; David A. Bond; Veronika Bachanova; Stefan K. Barta; Brian T. Hill; Peter Martin; Alexey V. Danilov; Natalie S. Grover; Reem Karmali; Nilanjan Ghosh; Timothy S. Fenske; Brad S. Kahl; Alexandra Albertsson-Lindblad; Ingrid Glimelius; Ahmed Ludvigsen Al-Mashhadi; Thomas S. Larsen; Kami J. Maddocks; Eric Mou; Jonas Paludo; Grzegorz S. Nowakowski; Thomas M. Habermann; Matthew J. Maurer; Diego Villa; Jonathon B. Cohen; Tarec C. El-Galaly; Mats Jerkeman; James R. Cerhan
deleteShare
deleteSave
Stem cell autograft minimal residual disease negativity and survival outcomes for multiple myeloma autotransplant
delete2026-09-22
delete0
deleteOAAI
deleteNoriko Nishimura; Samantha Brown; Sarah Samorodnitsky; Sean M. Devlin; Mohammad Alhomoud; Parastoo Dahi; Charlotte Hughes; Eric Jergens; Heather J. Landau; Oscar B. Lahoud; Michael Scordo; Gunjan L. Shah; Ross Firestone; Hamza Hashmi; Hani Hassoun; Malin Hultcrantz; Neha Korde; Alexander M. Lesokhin; Kylee Maclachlan; Sham Mailankody; Francesco Maura; Maximilian Merz; Sridevi Rajeeve; Urvi A. Shah; Carlyn R. Tan; Gaurav K. Gupta; Elena Maryamchik; Evangelos Ntrivalas; Qi Gao; Mikhail Roshal; Saad Z. Usmani; Sergio A. Giralt; David J. Chung
deleteShare
deleteSave
REVEAL-MM: retrospective evaluation of variables in early assessment and landmark trends in multiple myeloma—a US claims-based case-control study
delete2026-09-14
delete0
deleteOAAI
deleteFaith E. Davies; Beth Faiman; Hayley Beer; Anne Quinn Young; Katie Joyner; Kate Morgan; Stephen Huo; J. Blake Bartlett; Yi Han; Georgia Attfield; Daniel Egbase; Joseph Mikhael
deleteShare
deleteSave
Safety and efficacy of birelentinib, a novel LYN/BTK dual inhibitor, in relapsed/refractory diffuse large B-cell lymphoma: a phase 2 study (TAI-SHAN9)
delete2026-09-08
delete0
deleteOAAI
deleteYajun Li; Wei Liu; Keshu Zhou; Wenbing Qian; Ming Jiang; Meifang Zheng; Zhiming Li; Zengjun Li; Pengcheng He; Mei Lan; Hongmei Jing; Kaiyang Ding; Fang Zhu; Lihua Qiu; Ziyi Liu; Yu Bai; Lugui Qiu
deleteShare
deleteSave